Page 5 of 7
The Journal of Organic Chemistry
140.8, 142.4, 144.9, 147.7, 151.6, 158.4, 162.9; HRMS (ESIꢀ
13.3, 7.7 Hz, 1H), 1.33ꢀ1.40 (m, 1 H), 1.60ꢀ1.75 (m, 2H), 2.05 (s,
3H), 2.35 (br s, 1H), 2.82ꢀ2.89 (2H), 3.26ꢀ3.36 (m, 3H), 4.02 (s, 3H),
4.90 (d, J = 10.4 Hz, 1H), 5.00 (d, J = 17.1 Hz, 1H), 5.14 (br s, 1H),
5.55 (br s, 1H), 5.81(ddd, J = 17.4, 10.4, 7.2 Hz, 1H), 6.93 (br s, 1H),
7.14 (br s, 1H), 7.44 (dd, J = 9.2, 2.7 Hz, 1H), 7.64 (d, J = 4.5 Hz,
1H), 7.76 (br s, 1H), 8.01 (d, J = 9.2 Hz, 1H), 8.77 (d, J = 4.5 Hz,
1H); 13C NMR (100 MHz, CDCl3): δ = 25.8, 27.2, 27.6, 31.2, 34.6,
39.2, 40.7, 53.8, 55.2, 56.0, 62.7, 101.2, 115.1, 118.3, 118.8, 122.3,
127.1, 132.4, 140.8, 142.7, 145.1, 147.7, 158.5, 164.5; HRMS (ESIꢀ
TOF):Calcd for C25H29N6O (M+H)+:429.2403, Found: 429.2399;
Anal. Calcd for C25H28N6O: C,70.07; H, 6.59; N,19.61. Found: C,
69.91; H, 6.60; N, 19.48.
TOF):Calcd for C35H41N6O (M+H)+: 561.3342, Found: 561.3316.
1
2
3
4
5
6
7
8
Organocatalyst 5
Yellow powder (158.8 mg, 63%); mp 100ꢀ103 °C; [α]29D = ꢀ184.8 °(c
1
1.0, CHCl3); H NMR (400 MHz, CD3OD): δ = 0.93ꢀ0.98 (m, 1H),
1.26ꢀ1.33 (m, 2H), 1.63 (br s, 3H), 2.32 (br s, 1H), 2.64ꢀ2.72 (m, 1H),
2.77ꢀ2.82 (m, 1H), 3.06ꢀ3.13 (br m, 1H), 3.06ꢀ3.24 (m, 2H), 3.98 (s,
3H), 4.35 (d, J =14.5 Hz, 1H), 4.46 (d, J =14.7 Hz, 1H), 4.93 (d, J =
10.4 Hz, 1H), 4.99 (d, J = 17.2 Hz, 1H), 5.75 (ddd, J = 17.2, 10.1, 7.3
Hz, 1H), 6.88 (br s, 2H), 7.17ꢀ7.24 (m, 3H), 7.29 (d, J =3.8 Hz, 1H),
7.47 (dd, J = 9.3, 2.6 Hz, 1H), 7.59 (br s, 1H), 7.99 (d, J = 9.2 Hz,
1H), 8.54 (d, J = 4.6 Hz, 1H); 13C NMR (100 MHz, CDCl3): δ = 25.6,
27.1, 27.4, 34.9, 39.1, 40.0, 49.0, 53.2, 54.8, 55.7, 63.1, 100.7, 115.1,
118.1, 118.6, 122.3, 128.0, 128.4, 129.1, 132.5, 135.7, 140.7, 142.2,
145.1, 147.6, 158.5, 163.0; HRMS (ESIꢀTOF):Calcd for C31H33N6O
(M+H)+:505.2716, Found: 505.2725.
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
29
30
31
32
33
34
35
36
37
38
39
40
41
42
43
44
45
46
47
48
49
50
51
52
53
54
55
56
57
58
59
60
Typical procedure for asymmetric conjugate addition and char-
acterization data of the products (12aa-12al).
To a solution of organocatalyst 7 (9.1 mg, 0.020 mmol), 1ꢀ
propenylpropꢀ2ꢀenꢀ1ꢀone (11a4, 26.4 mg, 0.20 mmol) in toluene (0.6
mL) were added 2ꢀoxocyclopentaneꢀ1ꢀcarbonitrile (10a4, 20.0 ꢁL,
0.20 mmol) at ꢀ50 °C for 24 h. The reaction mixture was directly
purified by flash column chromatography on silica gel with a 3:1
mixture of hexane and ethyl acetate to afford the pure 12aa (42.5 mg,
88%) as a white solid.
Oganocatalyst 6
White powder (215.2 mg, 91%); mp 93ꢀ94 °C; [α]29 = ꢀ191.7 °(c
D
1
1.0, CHCl3); H NMR (400 MHz, CDCl3): δ =0.73 (brs, 3H), 0.86ꢀ
1.12 (m, 6H), 1.39ꢀ1.44 (m, 1H), 1.63 (br s, 2H), 1.73 (br s, 1H), 2.35
(br s, 1H), 2.81ꢀ2.88 (br m, 2H), 3.04 (br s, 1H), 3.15ꢀ3.33 (m, 4H),
3.99 (s, 3H), 4.99 (d, J = 10.0 Hz, 1H), 5.01 (d, J = 17.0 Hz, 1H), 5.10
(br s, 1H), 5.66ꢀ5.74 (m, 1H), 6.40 (br s, 1H), 7.35 (br s, 2H), 7.47
(S)ꢀ2ꢀOxoꢀ1ꢀ(3ꢀoxoꢀ3ꢀphenylpropyl)cyclopentaneꢀ1ꢀcarbonitrile
(12aa)4. White solid, 42.5 mg, 88% yield (94% ee). 1H NMR (400
MHz, CDCl3): δ =2.07ꢀ2.18 (m, 4H), 2.32 (ddd, J = 5.6, 9.4, 14.6 Hz,
1H), 2.45ꢀ2.52 (m, 3H), 3.22 (ddd, J = 5.5, 9.5, 18.0 Hz, 1H), 3.41
(ddd, J = 5.6, 9.5, 18.0 Hz, 1H), 7.49 (dd, J = 7.8, 7.6 Hz, 2H), 7.57ꢀ
7.61 (m, 1H), 7.98 (dd, J = 1.3, 7.9 Hz, 2H); 13C NMR (100 MHz,
CDCl3): δ = 19.2, 28.0, 34.0, 35.2, 36.3, 47.9, 118.9, 128.1, 128.7,
133.5, 136.3, 198.0, 209.2; [α]29D = 9.0° (c 1.0, CHCl3); Enantiomeric
excess of the product was determined by chiral stationary phase
HPLC analysis using a CHIRALPAK IA column (hexane/iꢀPrOH =
90:10 at 1.0 mL/min); λ = 254 nm; t major = 16.2 min, t minor = 14.0
min.
(dd, J = 9.1, 1.7 Hz, 1H), 8.11 (d, J = 9.2 Hz, 1H), 8.81 (br s, 1H); 13
C
NMR (100 MHz, CDCl3): δ = 13.5, 19.6, 25.8, 27.2, 27.7, 31.6, 34.6,
39.3, 40.7, 44.6, 53.2, 55.3, 55.9, 63.0, 100.8, 115.2, 118.3, 119.2,
122.5, 127.2, 132.7, 140.9, 142.5, 145.1, 147.8, 158.7, 163.4; HRMS
(ESIꢀTOF):Calcd for C28H35N6O (M+H)+:471.2872, Found: 471.2872.
Oganocatalyst 7
Yellow powder (2.0 g, 99%); mp 234ꢀ236 °C; [α]29 = ꢀ200.5 °(c
D
1.0, CHCl3); 1H NMR (400 MHz, CDCl3): δ = 0.62 (t, J =7.4 Hz, 3H),
0.87ꢀ0.91(m, 1H), 1.07ꢀ1.20 (m, 2H), 1.38ꢀ1.41 (m, 1H), 1.62 (br s,
2H), 1.72 (br s, 1H), 2.34 (br s, 1H), 2.80ꢀ2.87 (m, 2H), 3.09ꢀ3.14 (m,
3H), 3.21ꢀ3.27 (m, 2H), 3.99 (s, 3H), 4.98 (d, J = 13.0 Hz, 1H), 5.01
(d, J = 17.2 Hz, 1H), 5.26 (br s, 1H), 5.70 (br s, 1H), 6.80 (br s, 1H),
7.37 (d, J = 4.4 Hz, 1H), 7.39 (br s, 1H), 7.45 (dd, J = 9.2, 2.3 Hz,
1H), 8.08 (d, J = 9.2 Hz, 1H), 8.79 (br s, 1H); 13C NMR (100 MHz,
CDCl3): δ = 10.8, 22.8, 25.7, 27.2, 27.6, 34.4, 39.2, 40.6, 46.4, 53.2,
55.2, 55.9, 63.0, 100.7, 115.0, 118.4, 118.8, 122.4, 127.4, 132.5,
140.8, 142.6, 145.0, 147.7, 158.6, 163.3; HRMS (ESIꢀTOF):Calcd for
C27H33N6O (M+H)+:457.2716, Found: 457.2714. Anal. Calcd for
C27H32N6O: C,71.03; H, 7.06; N,18.41. Found: C, 70.92; H, 7.06; N,
18.14.
(S)ꢀ2ꢀOxoꢀ1ꢀ(3ꢀoxoꢀ3ꢀ(pꢀtolyl)propyl)cyclopentaneꢀ1ꢀcarbonitrile
(12ab) 4. White solid, 56.3 mg, 99% yield (88% ee). 1H NMR (400
MHz, CDCl3): δ =2.06ꢀ2.18 (m, 4H), 2.31 (ddd, J = 5.6, 9.4, 14.6 Hz,
1H), 2.42 (s, 3H), 2.44ꢀ2.53 (m, 3H), 3.19 (ddd, J = 5.5, 9.6, 18.0 Hz,
1H), 3.38 (ddd, J = 5.6, 9.6, 17.9 Hz, 1H), 7.28 (d, J = 8.1 Hz, 2H),
7.88 (d, J = 8.1 Hz, 2H); 13C NMR (100 MHz, CDCl3): δ = 19.3, 21.8,
28.1, 33.9, 35.3, 36.4, 48.0, 119.0, 128.3, 129.5, 133.9, 144.5, 197.7,
209.3 [α]26D = 9.3° (c 1.0, CHCl3); Enantiomeric excess of the prodꢀ
uct was determined by chiral stationary phase HPLC analysis using a
ChiralCel ADꢀH column (hexane/iꢀPrOH = 90:10 at 1.0 mL/min); λ =
254 nm; t major = 16.7 min, t minor = 15.2 min.
(S)ꢀ2ꢀOxoꢀ1ꢀ(3ꢀoxoꢀ3ꢀ(mꢀtolyl)propyl)cyclopentaneꢀ1ꢀcarbonitrile
(12ac) 4. White solid, 45.3 mg, 89% yield (92% ee). 1H NMR (400
MHz, CDCl3): δ =2.04ꢀ2.17 (m, 4H), 2.32 (ddd, J = 5.6, 9.3, 14.6 Hz,
1H), 2.43 (s, 3H), 2.45ꢀ2.52 (m, 3H), 3.21 (ddd, J = 5.5, 9.5, 18.0 Hz,
1H), 3.40 (ddd, J = 5.5, 9.5, 18.0 Hz, 1H), 7.35ꢀ7.41 (m, 2H), 7.77ꢀ
7.78 (m, 2H); 13C NMR (100 MHz, CDCl3): δ = 19.2, 21.3, 28.0, 34.0,
35.2, 36.3, 47.9, 118.9, 125.3, 128.48, 128.53, 134.2, 136.3, 138.5,
198.1, 209.2; [α]26D = 8.2° (c 1.0, CHCl3); Enantiomeric excess of the
product was determined by chiral stationary phase HPLC analysis
using a ChiralCel ADꢀH column (hexane/iꢀPrOH = 90:10 at 1.0
mL/min); λ = 254 nm; t major = 15.3 min, t minor = 14.1 min.
Oganocatalyst 8
White powder (370.2 mg, 28%); mp 227ꢀ228 °C; [α]29D = ꢀ212.8 °(c
1.0, CHCl3); 1H NMR (400 MHz, CDCl3): δ =0.82 (t, J =7.2 Hz, 3H),
0.87 (dd, J =13.5, 7.2 Hz, 1H), 1.38ꢀ1.44 (m, 1H), 1.61ꢀ1.65 (m, 2H),
1.74 (br s, 1H), 2.35 (br s, 1H), 2.81ꢀ2.88 (m, 2H), 3.05 (br s, 1H),
3.23ꢀ3.29 (m, 2H), 3.34ꢀ3.43 (m, 2H), 3.99 (s, 3H), 5.00 (d, J = 10.0
Hz, 1H), 5.02 (d, J = 17.2 Hz, 1H), 5.14 (br s, 1H), 5.66ꢀ5.75 (m, 1H),
6.69 (br s, 1H), 7.35 (br s, 2H), 7.47 (dd, J = 9.2, 2.2 Hz, 1H), 8.11 (d,
J = 9.2 Hz, 1H), 8.80 (br s, 1H) ; 13C NMR (100 MHz, CDCl3): δ =
14.5, 25.7, 27.1, 27.6, 34.4, 39.2, 39.6, 40.6, 53.2, 55.2, 55.9, 62.9,
100.8, 115.1, 118.3, 118.8, 122.4, 127.4, 132.5, 140.8, 142.6, 145.0,
147.7, 158.6, 163.2; HRMS (ESIꢀTOF):Calcd for C26H31N6O
(M+H)+:443.2559, Found: 443.2553; Anal. Calcd for C26H30N6O:
C,70.56; H, 6.83; N,18.99. Found: C,70.33; H, 6.87; N, 18.90.
(S)ꢀ1ꢀ(3ꢀ(3,4ꢀDimethylphenyl)ꢀ3ꢀoxopropyl)ꢀ2ꢀoxocyclopentaneꢀ1ꢀ
carbonitrile (12ad) 4. Colorless oil, 43.4 mg, 81% yield (91% ee). 1H
NMR (400 MHz, CDCl3): δ =2.06ꢀ2.17 (m, 4H), 2.27ꢀ2.35 (m, 1H),
2.33 (s, 6H), 2.43ꢀ2.51 (m, 3H), 3.18 (ddd, J = 5.5, 9.5, 17.9 Hz, 1H),
3.37 (ddd, J = 5.5, 9.5, 17.9 Hz, 1H), 7.23 (d, J = 7.8 Hz , 1H), 7.71
(dd, J = 1.7, 7.8 Hz, 1H), 7.74 (brs, 1H); 13C NMR (100 MHz,
CDCl3): δ = 19.2, 19.8, 20.0, 28.0, 33.8, 35.2, 36.3, 48.0, 119.0,
125.8, 129.2, 129.9, 134.3, 137.1, 143.1, 197.8, 209.2; [α]29D = 10.0°
(c 1.0, CHCl3); Enantiomeric excess of the product was determined by
Oganocatalyst 9
White powder (734.1 mg, 57%); mp: 223ꢀ226 °C; [α]29 = ꢀ156.1
D
1
°(c 1.0, CHCl3); H NMR (400 MHz, (CD3)2CO): δ =1.07 (dd, J =
ACS Paragon Plus Environment